You are viewing a free limited preview of NeuroNova AB
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access

NeuroNova AB

NeuroNova AB has been acquired by a public company.
PrivCo has ceased its coverage of NeuroNova AB and below is the archived report.

Business Summary

NeuroNova AB, a biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of central nervous system disorders. It was acquired by Newron Pharmaceuticals, a public company, in June 2012.

Overview & Corporate Organization

Basic Information

Fiscal Year End:12/31
City:Stockholm
Country:Sweden
Website:www.neuronova.com

Industry Information

Industry Codes

PICS™:7008™, 15001
NAICS:View
SIC:View

PrivCo Industries (Sector > Industry > Sub-Industry)

Healthcare > Pharmaceuticals
Technology > Biotechnology

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

Mergers & Acquisitions

PrivCo's M&A Activity table for NeuroNova AB displays the mergers and acquisitions involving NeuroNova AB, for example if NeuroNova AB acquired or was acquired by another entity, any leveraged buyout (LBO), etc.
All data before 2006 is completely free to view! To access data from 2006 onward:
Get Full Access To This Report Now! $99 Single Company Access
 
or Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateStatusTargetBuyerDeal TypePrice
DetailsJun. 2012CompletedView1ViewAcquisition
Direct Share Purchase
View
Notes
1Investor AB and HealthCap, holders...Read More →
Full-length notes are available with Single Report Access or PrivCo Premium Subscription.

Missing a deal? Tell us about it! tips@privco.com

Supplemental Resources

For additional information on NeuroNova AB, you can see the following:

You are viewing a free limited preview of NeuroNova AB
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access